RCT: Effect of capecitabine maintenance therapy plus best supportive care vs. best supportive care alone on progression-free survival among patients with newly diagnosed metastatic nasopharyngeal carcinoma who had received induction chemotherapy.

Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)

Commentary on Twitter

Randomized trial of efficacy and safety of capecitabine maintenance therapy in metastatic nasopharyngeal carcinoma demonstrates that capecitabine maintenance therapy improved survival & was associated with manageable toxicities. https://t.co/Ay2WZ7ZuCN pic.twitter.com/sZJ6qfzCOY

— JAMA Oncology (@JAMAOnc) February 17, 2022